Optical Research for Biopsy Triaging

DynamX Medical have recently completed a Phase 2 in-clinic trial on oesophageal cancer and colon cancer.  This trial was performed at four independent sites across the UK. 

400 patient in-clinic trial, deploying the system bedside at 4 NHS endoscopy units, enabling us to validate clinical performance and ensure seamless integration with established clinical workflows.

System usability was tested over a wide range of users including research nurses, endoscopists and health care assistants.

Initial analysis of the study data shows improved performance over the previous Phase 1 clinical trial, enabling significant reduction in the workload for pathology services and expansion of screening programmes.

DynamX Medical is advancing diagnostics

As well as developing diagnostic devices for the oesophageal and colon cancer we also work on other diseases.